Stéphane Legastelois

Stéphane Legastelois

Director/Board Member at BIOCORP
66 year
Health Technology
Finance
Commercial Services

Profile

Stéphane Legastelois is the founder of Sirius NeoSight SAS (2023).
Current jobs include Chairman & Chief Executive Officer at Indicia Production SASU, Chief Executive Officer at Platine Pharma Services SAS, Chairman at Indicia Développement SA, Chairman at Indicia Participations, Chairman at 33 Californie SAS (Lentilly) since 2004, Chairman at Mexbrain SAS, Chairman at Simba Sante 3 SAS since 2020, Director at BioAster, Independent Director at BIOCORP Production SA since 2015, Director at Jalon Therapeutics, Co-Manager at Camilla SNC, Partner at Angelor SAS, and Manager at SCI CALIFORNIE.
Former jobs include Chairman at Mabdesign Association, Chairman at TransCure BioServices SASU, Director at Boiron SA, and Manager at Sci La Parliere.

Stéphane Legastelois active positions

CompaniesPositionStart
BIOCORP Director/Board Member 12/05/2015
33 Californie SAS (Lentilly)
Chairman 02/11/2004
Director/Board Member -
Chairman 27/06/2020
Chairman -
Corporate Officer/Principal -
Chief Executive Officer -
Chairman -
Director/Board Member -
░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ -

Former positions of Stéphane Legastelois

CompaniesPositionEnd
░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░ -
░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░░░ -
░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Stéphane Legastelois's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

13

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies17

Health Technology

Finance

Health Technology

Finance

Health Services

Commercial Services

Health Technology

Technology Services

Indicia Développement SA

Commercial Services

Sci La Parliere

Finance

Finance

33 Californie SAS (Lentilly)

Health Technology

Finance

Health Technology

  1. Stock Market
  2. Insiders
  3. Stéphane Legastelois